Abeona Therapeutics (ABEO) Return on Sales [ROS] (2011 - 2026)
Abeona Therapeutics (ABEO) posted Return on Sales [ROS] of -119.97% for Q2 2026, up 5578.03 percentage points from -5698.00% a year earlier and up 144.17 percentage points from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Abeona Therapeutics was -327.64%, up 18306.36 percentage points year-over-year; for FY2025, it came in at -1536.91%.
- Annual Return on Sales [ROS] shows a five-year change of -722.71 percentage points (FY2020 to FY2025).
- In prior years, Abeona Therapeutics' Return on Sales [ROS] was -1346.71% in FY2023 (+2254.06 pp), -3600.78% in FY2022 (-606.24 pp) and -2994.53% in FY2021 (-2180.33 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q3 2020.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -264.14% (Q1 2026), -422.71% (Q4 2025) and -20802.25% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Abeona Therapeutics | 287.85 Mn | -426.11 Mn | 7.20 Mn | -119.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -119.97% |
| Mar 31, 2026 | -264.14% |
| Dec 31, 2025 | -422.71% |
| Sep 30, 2025 | -20,802.25% |
| Jun 30, 2025 | -5,698.00% |
| Mar 31, 2024 | -1,412.20% |
| Dec 31, 2023 | -1,346.71% |
| Sep 30, 2023 | -1,313.40% |
| Jun 30, 2023 | -301.54% |
| Mar 31, 2023 | -3,966.48% |
| Dec 31, 2022 | -19,023.53% |
| Sep 30, 2022 | -1,947.33% |
| Jun 30, 2022 | -800.80% |
| Mar 31, 2022 | -5,951.16% |
| Dec 31, 2020 | -482.67% |
| Sep 30, 2020 | -89.26% |
| Jun 30, 2019 | -3,558.01% |
| Mar 31, 2019 | -2,697.08% |
| Dec 31, 2018 | -3,736.51% |
| Sep 30, 2018 | -989.82% |
API Access
Abeona Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();